Press Releases April 30, 2026 05:00 PM

Xometry to Participate in Upcoming Investor Conferences

Xometry Announces Participation in Major Upcoming Investor Conferences

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
XMTR

Xometry, Inc., a leading AI-native custom manufacturing marketplace, announced its management team's participation in the J.P. Morgan 2026 Global Technology, Media and Communications Conference and the William Blair 46th Annual Growth Stock Conference, with details available via webcast and replay on the company's website.

Xometry to Participate in Upcoming Investor Conferences
XMTR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Xometry will participate in two prominent investor conferences in May and June 2026, featuring a fireside chat and a presentation.
  • The company's AI-native marketplace is digitizing manufacturing by providing real-time pricing and lead time data to streamline procurement.
  • These events offer Xometry an opportunity to engage with investors and showcase its growth prospects and technology platform.

NORTH BETHESDA, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Xometry, Inc. (NASDAQ:XMTR), the global, AI-native marketplace connecting buyers and suppliers of custom manufacturing, announced that members of its management team will attend the following investor events:

  • J.P. Morgan 2026 Global Technology, Media and Communications Conference: Tuesday, May 19, in Boston – including a fireside chat at 11:25 a.m. ET
  • William Blair 46th Annual Growth Stock Conference: Thursday, June 4, in Chicago – including a presentation at 8:00 a.m. CT

The webcast and replay of the fireside chat will be accessible within the Investor Relations section of Xometry’s website following the session.

About Xometry
Xometry’s (NASDAQ: XMTR) AI-native marketplace, popular Thomasnet® industrial sourcing platform and suite of cloud-based services are rapidly digitizing the manufacturing industry. Xometry provides manufacturers the critical resources they need to grow their businesses and streamlines the procurement process for buyers through real-time pricing and lead time data. Learn more at xometry.com or follow Xometry on LinkedIn.

Investor Contact
Shawn Milne
VP, Investor Relations
240-335-8132
Shawn.Milne@xometry.com

Media Contact
Lauran Cacciatori
VP, Communications
773-610-0806
lauran.cacciatori@xometry.com


Risks

  • Market acceptance and growth projections depend on continued adoption of AI-driven manufacturing technologies, which face competitive and technological risks.
  • Economic fluctuations could impact demand in the manufacturing sector, affecting Xometry's business volume and revenues.
  • The company’s stock performance may be influenced by investor reaction to conference presentations and future operational results.

More from Press Releases

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026 Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026